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Abstract 
BACKGROUND: Studies have shown that administration of anthelmintic drugs in pregnancy can reduce the 
incidence of maternal anaemia; however, data on other maternal and perinatal outcomes are limited. 
AIM: This study was therefore conducted to evaluate the direct impact of mass deworming on delivery and 
perinatal outcome. 
MATERIAL AND METHODS: A total of 560 healthy pregnant women in their second trimester were randomised 
to receive a single dose of oral mebendazole (500 mg) and placebo. Each participant received the standard dose 
of iron supplement and malaria prophylaxis. They were followed up to delivery and immediate postpartum period 
to document the possible impact on maternal and perinatal outcomes. 
RESULTS: The prevalence of anaemia at term, 37 weeks gestation and above, among the treatment arm was 
12.6% compared with 29.9% in the placebo arm (p < 0.001). Caesarean section rates was higher in the treated 
group and the placebo (p = 0.047).There were no statistically significant differences in incidences of postpartum 
haemorrhage (p = 0.119), Puerperal, pyrexia (p = 0.943), low birth weight (p = 0.556) asphyxia (p = 0.706) and 
perinatal death (p = 0.621). 
CONCLUSION: Presumptive deworming during the antenatal period can significantly reduce the incidence of 
peripartum anaemia. However, more studies may be needed to prove any positive perinatal outcome. 
 
 
 
 
 
Introduction 
 
Intestinal parasitic infections are of public 
health importance because of likely morbidity related 
to iron deficiency anaemia due to chronic blood loss 
suffered by the hosts [1]. The burden is much for 
children and pregnant women because of the 
increased requirement for iron and other nutrients [2]. 
About two decades ago, a study in the general 
population in Calabar by Ejezie GC and Akpan IF [3] 
showed a high prevalence of intestinal nematodes of 
28.5% and recently, 23.6% prevalence has been 
reported by Ozumba UC et al., [4] among pregnant 
women at a University Teaching Hospital, in Southern 
Nigeria. However, these studies did not assess the 
correlation with anaemia among the subjects which 
necessitates more prospective studies to determine 
the impact of this high helminths prevalence on the 
haematological status and pregnancy outcome in the 
pregnant populace. 
It has been reported that majority of the 
pregnant women in the tropics have depleted or 
borderline iron stores due to menstrual blood loss and 
the demands of previous pregnancies, and only a few 
women in low-income countries begin pregnancy with 
sufficient iron stores [5] [6] [7] [8]. Combined with the 
increased iron demands in pregnancy due to the 
expansion in red cell mass and the requirement of the 
developing foetus, many women become iron 
deficient during childbearing [4]. The prevalence of 
iron deficiency anaemia in pregnancy is quoted at 
56% in developing countries [7]. Hence, parasitic 
diseases particularly soil-transmitted intestinal 
helminthic infections are important public health 
problems confronting many women in the developing 
countries [6] [8]. 
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Furthermore, it is estimated that anaemia may 
be responsible for as much as 20% of all maternal 
deaths in sub-Saharan Africa through three main 
mechanisms [9]: Firstly, anaemia makes women more 
susceptible to deaths from haemorrhage by lowering 
their haemoglobin reserves for blood loss especially at 
birth. Severe anaemia is associated with increased 
susceptibility to infection due to lowered resistance to 
disease, and haemoglobin level of less than 4 g/dl is 
associated with high-risk cardiac failure, particularly 
during delivery or in the immediate post-partum 
period, making the women likely to die if not properly 
managed [9]. 
Although it is widely believed that deworming 
can improve anaemic status in pregnant women [10]  
[11] little information is available about the degree to 
which anaemia improves after deworming in Calabar 
and improvement in the pregnancy outcome. Hence, it 
is necessary to conduct this randomised controlled 
study to suggest effective evidence-based methods of 
controlling anaemia and improving maternal health. 
And despite WHO recommendation of a single dose 
of Albendazole or Mebendazole treatment after the 
first trimester for infected pregnant women and mass 
policy (presumptive treatment) in areas where the 
infection is endemic (prevalence>20-30%) and where 
anaemia is highly prevalent, [12] it is yet to be 
included in routine antenatal care package in the 
University of Calabar Teaching Hospital, Calabar and 
many other tertiary health institutions in Nigeria. Low 
birth weight due to maternal chronic anaemia is a 
major factor influencing neonatal and infant survival. 
So treatment of helminthiasis in pregnancy may be 
beneficial to maintain appropriate fetal weight [12] 
[13]. Anthelminthics alone may halt the iron loss, or 
reduce the rate of loss, and the addition of iron 
supplements is likely to improve the haemoglobin or 
packed cell volume (PCV) levels.  
This study was therefore conducted to 
evaluate the direct impact of mass deworming on 
delivery and perinatal outcome. 
 
 
Material and Methods 
 
The research was conducted at the University 
of Calabar Teaching Hospital Antenatal Clinic from 1st 
January to 31st December 2015. The hospital is the 
only tertiary health facility in Calabar Metropolis, the 
capital of Cross River State which is located in South-
South Zone of Nigeria. A review of antenatal records 
revealed that the hospital provides obstetrics services 
to between 1500 and 2200 pregnant women annually. 
The hospital practices routine antenatal care 
schedules, i.e. four weekly visits for the 1st 28 weeks 
after that 2 weekly till 36 weeks, then weekly till 
delivery. The study population comprised all 
consenting women attending antenatal care at the 
University of Calabar teaching hospital who meet the 
criteria during the study period. 
Of the 560 participants in this study, 300 
received mebendazole while 260 made up the 
placebo arm. A sample size of 300 was adopted for 
the treatment arm using Leslie Kish formulae. The 
actual calculated sample size was 280 but to cater for 
attrition or “drop out” 300 women were recruited into 
the treatment arm. The sample size was determined 
using 23.6% prevalence from a recent study among 
pregnant women with precision at 0.05 and 95% 
confidence interval.  
Women who presented for antenatal care at 
the University of Calabar teaching hospital were 
recruited in their second trimester during the study 
period. The research and its purpose and expected 
benefits to the patients and the community were 
explained, and consent was obtained from the willing 
participants. To facilitate easy completion of 
questionnaires, semi-structured and closed-ended 
questions were used. Consenting women were 
assured of confidentiality. They were informed that no 
money would be charged for the test performed or for 
the anthelminthic/placebo drugs. 
This was a randomised placebo-controlled 
study. The study consisted of two groups of pregnant 
women, the treatment and the placebo group. The 
study design was suitable for this particular research 
because the placebo group constituted the baseline of 
what can be assumed to be expected the outcome in 
normal circumstances without treatment. The 
participants were assessed for eligibility using the 
inclusion and exclusion criteria below. The women 
were then randomised to receive either a single 500 
mg oral dose of Mebendazole plus a daily iron 
supplement, (60 mg elemental iron) and folic acid or a 
single dose placebo plus a daily iron supplement (60 
mg elemental iron) and folic acid. The administration 
of the anthelmintics was done by directly observed 
therapy (DOT) to ensure 100% compliance. 
Computer-generated random numbers were used for 
sampling. Single tablet (500 mg) of mebendazole was 
wrapped in a paper and labelled with a number for 
identification from the placebo which was also 
wrapped with same paper to blind the patients and the 
dispenser. Presumptive treatment was adopted in this 
study due to ethical issues in leaving some women 
with proven infections from stool microscopy 
untreated. All the participants received intermittent 
preventive treatment for malaria (IPT) according to the 
National protocol. The baseline packed cell volume 
(PCV) was noted at recruitment. All the participants in 
both the treatment and the placebo groups were then 
followed up to term and delivery. The maternal and 
perinatal outcomes were documented. Outcomes of 
interest included the prevalence of peripartum 
anaemia (PCV < 33%), mode of delivery post-partum 
haemorrhage, and other maternal morbidity like 
puerperal pyrexia; perinatal outcome included the 
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proportion of low birth weight, birth asphyxia, 
congenital abnormally and perinatal mortality. 
 
Figure 1: Summary of the study design (Flow diagram)  
 
Data were collected using pre-tested 
interviewer-administered questionnaire which contains 
socio-demographic characteristics (age, educational 
qualification, occupation, the occupation of spouse 
marital status, place of resident) obstetric and 
gynaecological history; drug history (haematinics, 
antimalarial, anthelminthics) and previous drug 
reaction or allergy; past and present medical and 
surgical history. 
Data were analysed using SPSS version 19. 
Description of means, frequency, proportions and 
rates of given data for each variable was calculated. 
Bivariate analysis was done to see the association of 
each independent variable with the outcome variable. 
A multivariate logistic regression model was used to 
identify the effect of each independent variable with 
the outcome variable. A p value of less than 0.05 was 
considered statistically significant. 
 
Inclusion criteria: 1) consenting women; 2) 
gestational age from 14 weeks to 28 weeks by LMP or 
ultrasound, and 3) singleton pregnancy. 
 
Exclusion criteria: 1) history of vaginal 
bleeding in current pregnancy; 2) medical, surgical or 
obstetric complication; 3) diagnosed or suspected 
multiple pregnancies; 4) patients with 
haemoglobinopathy; 5) women with moderate to 
severe anaemia; and 6) allergy to Mebendazole or 
sulphadoxine. 
Formal approval was obtained from the 
research ethics committee of the University of Calabar 
Teaching Hospital before the research was 
commenced. Written informed consent was obtained 
from each study participant after they were introduced 
to the purpose of the study and informed about their 
right to interrupt the researcher or withdraw at any 
time. Women who were detected to be anaemic were 
given appropriate treatment. Confidentiality was 
maintained at all levels of the research. 
The research assistants were trained in 
history taking, physical examination and data 
recording. They were trained on filling the 
questionnaire in a standard way. Haematological tests 
were done in the same laboratory. The laboratory 
internal and external quality control measures were 
adhered to. A haematologist reviewed the 
haemograms. There was a meticulous recording of 
laboratory investigation results. The same haematinic 
was given to all the participants. To avoid 
contamination of placebo group with the treatment 
arm, each participant’s folder was identified with a 
number on a sticker which helped the investigator to 
differentiate them. This was also used to follow-up the 
women to term and delivery. The sticker was removed 
at the time of discharge from the hospital before the 
folder was sent to health record department for filing.  
 
 
Results 
 
Out of the 300 women recruited into the 
treatment arm, 281 (93.7%) of them continued till 
delivery giving a drop-out rate of 6.33%. The mean 
age of respondents in both groups was similar; 29.3 ± 
4.4 years for the study group and 29.7 ± 4.6 years for 
the control group (p = 0.062). Table 1 summarises the 
socio-demographic characteristics of respondents. 
Table 1: Socio-demographic characteristics of respondents by 
group 
Variable Study 
N = 286 
Freq (%) 
Control 
N = 244 
Freq (%) 
Total 
N = 530 
Freq (%) 
X2 P-value 
Age (years)      
< 20 4 (1.4) 1 (0.9) 5(0.9) Fisher’s Exact 0.062 
20-29 136 (47.6) 118 (48.4) 254 (47.9)   
30-39 146 (51.0) 120 (49.2) 266 (50.2)   
> 40 0 (0.0) 5 (2.0) 5 (0.9)   
Mean +SD 29.3 ± 4.4 29.7 ± 4.6 29.5 ± 4.5   
Residence      
Urban 276 (96.5) 234 (95.9) 510 (96.2)   
Rural 10 (3.4) 20 (3.8) 10 (4.1) Fisher’s Exact 0.825 
Parity      
0 96 (33.6) 49 (20.1) 145 (27.4)   
1-4 187 (65.4) 187 (76.6) 374 (70.6) 14.269 0.001* 
> 4 3 (1.0) 8 (3.3) 11 (2.1)   
 
A higher proportion of participants in the 
control group (29.9%) compared with the study group 
(12.6%) had anaemia at term. The PCV difference of 
respondents in the study and control groups was 
assessed. Participants with a positive difference were 
more (57.0%) in the Mebendazole group compared 
with (29.9%) in the placebo group. Those with either 
no difference or negative difference were more (22% 
and 61.1% respectively) in the control group 
compared with the study group (6.3% and 36.7% 
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respectively). These differences were statistically 
significant (p < 0.001). In the mebendazole group, 
64.3% of the anaemic women had mild anaemia (Hb = 
10 to 10.9 g/dl) while the remaining (35%) had 
moderate anaemia (7 to 9.9 g/dl). There was no 
incidence of severe anaemia in the treatment arm (Hb 
< 7.0 g/dl). One case of severe anaemia was noted in 
the placebo group while 79.2% and 19.4% of the 
reported anaemia in this group was mild and 
moderate respectively. 
Table 2 shows multivariate logistic regression 
analysis of factors associated with anaemia among 
study respondents. Only parity (OR = 5.063, 95% CI = 
1.531-16.743) was found to be an independent 
predictor of anaemia among the study group. Those 
with parity above 3 were significantly more likely to 
have anaemia at term. 
Table 2: Determinants of anaemia among respondents in the 
study group 
Characteristic Odds Ratio 95% Confidence interval P-value 
Age    
<29 1.815 0.816-4.039 0.144 
>29 1   
Parity >3 5.063 1.531-16.743 0.008 
Yes 1   
No 5.063    
Social class    
1 to 2  0.324-1.485 0.346 
3 to 5 1   
Gestational age at term    
<24 0.829 0.396-1.736 0.618 
>24 1   
Residence    
Urban 1.091 0.128-9.291 0.937 
Rural 1   
 
Table 3 below shows the birth weight group of 
respondents’ babies. Majority of respondents had 
babies with normal birth weight 455 (85.8%). This was 
slightly higher among study group 248 (86.7%) 
compared with control group 207 (84.4%). Overall, 40 
(7.5%) had babies with higher than normal birth 
weight, 4 kg and above, slightly higher in the study 
group 23 (8.0%) compared with control group 17 
(7.0%) while 20 (3.8%) had low birth weight babies, 
slightly lower in study group 9 (3.1%) compared with 
control group 11 (4.5%). These differences were not 
statistically significant (p = 0.556). The overall mean 
birth weight of babies was 3.23 ± 0.629 kg; 3.26 ± 
0.582 kg in the study group and 3.19 ± 0.679 
Table 3: Birth weight group of respondents’ babies by study 
arm 
Variable  
Birth weight group/Kg (%) 
Study group Control group Total 2 P-value 
ELBW (<1.0) 6 (2.1) 9 (3.7) 15 (2.8) 2.079 0.556 
VLBW (1-1.4) 0 (0.0) 0 (0.0) 0 (0.0)   
LBW (1.5-2.4) 9 (3.1) 11 (4.5) 0 (3.8)   
Normal (2.5-3.9) 248 (86.7) 207 (84.8) 455 (85.8)   
Macrosomia (≥4) 23 (8.0) 17 (7.0) 40 (7.5)   
Mean birth weight ± SD 3.23 ± 0.629 3.19 ± 0.679 3.26 ± 0.582   
 
Most of the participants, 94.7% in the study 
group and 95.1% in the controlled group, did not 
experience postpartum haemorrhage (PPH) while 
4.2% in the study group and 4.9% in the control group 
had PPH. The slight differences were not statistically 
significant (p = 0.119). Also, incidences of puerperal 
pyrexia were compared. Almost equal percentage in 
both study (94.8%) and control (94.3%) had no 
incidence of puerperal pyrexia, and almost equal 
proportion had pyrexia; 3.5% in the study group and 
3.7% in control group. There was no statistically 
significant difference in pyrexia by study arm (p = 
0.943). 
The perinatal deaths were: 2.9% in (29 per 
1000) study group and 3.3% (33 per 1000) in control 
group (Fig. 2).  
 
Figure 2: Perinatal death by a group 
 
Only two babies, one from each group, were 
born with a gross congenital anomaly. Furthermore, 
the incidences of birth asphyxia were comparable. 
The study shows the percentage of participants 
whose babies had asphyxia (5.6% in the study group 
and 7.05% in control group) and had no asphyxia 
(93.4% in the study group and 95.1% in control 
group). The slight difference in this experience was 
not significant statistically (p = 0.706). Table 3 
summarises proportion of normal birth weight (2.5-3.9 
kg), low birth weight (LBW), very low birth weight 
(VLBW) and extremely low birth weight (ELBW).  
 
Figure 3: Mode of delivery by study arm (p = 0.047); C/s = 
caesarean section; ND = Normal delivery; NF = Lost to follow up 
 
The study shows that more women who 
received mebendazole were delivered by caesarean 
section. Fig. 3 below shows the mode of delivery of 
participants by study arm. The majority of both study 
and control had normal delivery; 76.7% in the study 
group and 84.9% in control group. In the study group, 
22.4% delivered by C/S compared with 13.5% in the 
control group. 
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Discussion 
 
The drop-out rate of 6.33% in this study was 
similar to 7% obtained in a previous randomised trial 
in Uganda [14]. As every participant was dully 
counselled on the need for continued care at the 
centre, the drop-out could have been due to 
miscarriages, change of place of residents/relocation 
or other factors. The prevalence of anaemia at term 
(after treatment) in the study group was 12.6% and 
was significantly lower than the prevalence of 29.9% 
among the control/ placebo arm (p=0.000l). This 
statistically significant difference is the evidence of the 
negative effect of helminth infection on maternal 
haemoglobin concentration with associated impact on 
overall maternal health. Perhaps the elimination of 
intestinal parasites has significantly contributed to the 
reduction in the incidence of anaemia at term among 
the treated women. Several studies have found a 
strong association between anaemia and intestinal 
parasitic infestations [4] [15] [16] [17] [18]. 
In controlling for the co-founders or other 
related risk factors for anaemia using multiple logistic 
regression, the study shows that high parity was an 
independent risk factor for anaemia at term among the 
participants. The women with more than three 
previous pregnancies had significantly higher rates of 
anaemia. This is in keeping with findings from other 
studies especially in Africa and Latin America [19]. 
Also, a study in south India [20] reported a higher 
incidence of anaemia for the parity index more than 
four. This might be due to the increase in women's 
nutritional needs during pregnancy in the setting of 
low iron store especially due to short inter-pregnancy 
intervals. This further highlights the role of 
contraceptives in improving maternal health. 
The observed higher caesarean section rate 
among the treatment group might have been 
contributed by the relative increase in the incidence of 
macrosomic births (birth weight > 4.0 kg) among other 
indications. However, the study failed to show any 
significant statistical difference in the incidence of 
postpartum haemorrhage (p = 0.119), and puerperal 
pyrexia (p = 0.943) between the treatment and the 
placebo arms. Improved maternal care in the facility 
may have significantly reduced the risk of these 
morbidities since the study was conducted in a tertiary 
health centre with the availability of specialised care. 
The association between maternal anaemia and 
increased risk of postpartum haemorrhage has been 
reported. Significant anaemia may cause postpartum 
haemorrhage by impairing myometrial contraction 
(atony) following delivery [21]. Similarly, puerperal 
sepsis has been linked to peripartum anaemia [22]. In 
this study, most of the anaemic women had mild 
anaemia probably because of iron supplementation 
they received during pregnancy, and this might have 
influenced the low incidence of postpartum 
haemorrhage among the participants.  
In this study, although there was a remarkable 
improvement in the haematologic status of women 
treated with the anthelminthic drug in pregnancy, 
these did not significantly translate to improvement in 
fetal or neonatal well-being. The research showed a 
slightly higher mean birth weight in the study (3.26 ± 
0.582 kg) than the placebo group (3.19 ± 0.679). 
There was no statistically significant difference in low 
birth weight (p = 0.556). The incidence of very low 
birth weight and extremely low birth weight were very 
rare in this study. Also, there was no significant 
difference in perinatal death (p = 0.621) and birth 
asphyxia (p = 0.706). Two congenital abnormal infants 
were delivered, one in each group. Similar findings 
were documented in previous studies [28] [29]. 
Furthermore, several other studies on helminths 
infection and anaemia on pregnancy outcomes have 
yielded inconsistent results [30] [31] [32] [33] [34] [35] 
[36] [37] [38] [39] [40] [41] [42]. For instance, these 
findings in this study contrast with 2 previous 
observational studies [41] [42] in which women who 
received mebendazole or albendazole were compared 
with those who did not. One possible mechanism for a 
beneficial effect on birth weight would be through 
increased maternal haemoglobin level, and an effect 
of anthelminthics on perinatal mortality might be 
mediated by improved birth weight. It is possible that 
women in those other studies cited who missed one or 
both doses of albendazole may also have missed their 
haematinics doses. Similarly, the findings of a cross-
sectional study in Sierra Leone [42] in which a lower 
rate of perinatal deaths occurred among women who 
took mebendazole may have been affected by 
selection bias and unmeasured confounders due to 
lack of randomisation. 
 In our study since every participant received 
the standard dose of iron supplement in addition to 
malaria control strategy (IPT and LLIN) which possibly 
resulted in the overall decline in the prevalence of 
anaemia in both arms with very few of them having 
moderate to severe anaemia, the incidence of low 
birth weight was low. This must have impacted 
positively on the perinatal outcome in both groups. 
Low birth weight has been associated with other 
perinatal complications including birth asphyxia and 
perinatal death [34] [42]. Furthermore, deworming is 
important to prevent some direct pathological effects 
of worms on the newborn. This is because helminths 
infection has been linked to the long-term effect on the 
development of the foetal immune system and risks 
for disease susceptibility in later life [34]. 
In conclusion, mass deworming in pregnancy 
is effective in reducing the incidence of anaemia in 
advanced gestation. However mild to moderate 
anaemia may not significantly impact negatively on 
the perinatal outcomes. The same may not, however, 
apply to women who are not on routine iron and folic 
acid supplement during pregnancy as severe anaemia 
may worsen life-threatening obstetric complications 
and infant health. There is need to consider 2nd-
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trimester presumptive treatment for inclusion in our 
routine antenatal care practice.  
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